SEC EDGAR · company profile · free

JOHNSON & JOHNSON due diligence

Who JOHNSON & JOHNSON (JNJ) is on the public record: identity, industry classification and the most recent periodic filings, straight from SEC EDGAR.

1002 filings in EDGAR's recent index, 484 of them Form 4 insider filings · view the filings on SEC EDGAR · source: SEC EDGAR submissions index
CIK
0000200406
Industry (SIC)
Pharmaceutical Preparations (2834)
Incorporated
NJ
Listed on
NYSE
Tickers
JNJ
Fiscal year end
01-03
FilingFiledPeriodAccession
Annual report (10-K)2026-02-112025-12-280000200406-26-000016
Quarterly report (10-Q)2026-07-232026-06-280000200406-26-000153
Current report (8-K)2026-08-042026-08-040000200406-26-000167

The full due-diligence dossier on JOHNSON & JOHNSON

The free view above is identity and filing dates. The paid dossier reads the filings: business and segments, financial trend, insider and institutional activity, litigation and risk-factor themes, recent news, and the red flags, every claim cited and delivered with a data appendix.

agents: POST /v1/dossier with {"ticker":"JNJ"} over x402 or MPP, $9

Sample output and API docs · all reports

JNJ insider filingsAll company profiles13F fund holdingsAll reports

Generated from public SEC EDGAR filings. Filing data is shown as filed. This is information, not investment advice.